REQUEST A DEMO
Total
USD $0.00
Search more companies

Patula Pharma Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: Patula Pharma Kft. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

Patula Pharma Kft. is a company in Hungary, with a head office in Budapest. The company operates in the Pharmacies and Drug Stores industry. It was established on June 30, 2014. 8 (2023) employees currently work for Patula Pharma Kft.. The company’s latest financial report indicates a net sales revenue increase of 16.72% in 2022. Its’ total assets recorded a growth of 32.34%. The net profit margin of Patula Pharma Kft. increased by 1.99% in 2022.

Headquarters
Donati utca 44. 1. em. 7.
Budapest; Budapest; Postal Code: 1015

Contact Details: Purchase the Patula Pharma Kft. report to view the information.

Basic Information
Total Employees:
Purchase the Patula Pharma Kft. report to view the information.
Outstanding Shares:
Purchase the Patula Pharma Kft. report to view the information.
Registered Capital:
Purchase the Patula Pharma Kft. report to view the information.
Financial Auditors:
Purchase the Patula Pharma Kft. report to view the information.
Incorporation Date:
June 30, 2014
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Patula Pharma Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
16.72%
Total operating revenue
16.5%
Operating profit (EBIT)
44.23%
EBITDA
43.59%
Net Profit (Loss) for the Period
44.31%
Total assets
32.34%
Total equity
38.27%
Operating Profit Margin (ROS)
2.18%
Net Profit Margin
1.99%
Return on Equity (ROE)
3.74%
Quick Ratio
0.12%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?